Filters
reset allOther countries
Results: 1 to 10 of 10
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
BRCA1 and BRCA2 target mutation analysis GENETIX Centro de Investigación en Genética Humana y Reproductiva Colombia | 6 | 2 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics United States | 94 | 55 |
|
Inherited Bone Marrow Failure Panel PreventionGenetics United States | 268 | 187 |
|
PreventionGenetics United States | 20 | 16 |
|
Breast Cancer - High / Moderate Risk Panel PreventionGenetics United States | 13 | 14 |
|
Hereditary Breast and Ovarian Cancer - Expanded and Lynch Syndrome Panel PreventionGenetics United States | 29 | 33 |
|
Hereditary Breast and Ovarian Cancer - High Risk and Lynch Syndrome Panel PreventionGenetics United States | 19 | 17 |
|
Hereditary Ovarian Cancer Panel PreventionGenetics United States | 40 | 30 |
|
Breast Cancer - Expanded Risk Panel PreventionGenetics United States | 16 | 21 |
|
RAD51C Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
Results: 1 to 10 of 10
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.